Evidence map›Paper›PMID 41415251›Full record

ArticleFrontiers in public health2025

Scaling holistic e-health solutions in cancer care using a qualitative realist framework.

Samar J Melhem, Shereen Nabhani-Gebara, Nailya Bulatova, Ibrahim Alabbadi, Hamzeh Almomani, Rimal Mousa, Ahmed Almousa, Yazan AlRashdan, Omar Nimri, Reem Kayyali

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samar J MelhemDepartment of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, University of Jordan, Amman, Jordan.
Shereen Nabhani-GebaraDepartment of Pharmacy, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston upon Thames, United Kingdom.
Nailya BulatovaDepartment of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, University of Jordan, Amman, Jordan.
Ibrahim AlabbadiDepartment of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, University of Jordan, Amman, Jordan.
Hamzeh AlmomaniDepartment of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, University of Jordan, Amman, Jordan.
Rimal MousaDepartment of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, University of Jordan, Amman, Jordan.
Ahmed AlmousaDepartment of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, University of Jordan, Amman, Jordan.
Yazan AlRashdanDepartment of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, University of Jordan, Amman, Jordan.
Omar NimriCancer Prevention Department, Director of Cancer Registry, Ministry of Health, Amman, Jordan.
Reem KayyaliDepartment of Pharmacy, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston upon Thames, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: While e-health innovations have advanced cancer-care delivery in high-income countries, middle-income countries (MICs) face distinct systemic, infrastructural, and sociocultural challenges in adopting and scaling digital-health interventions. There is a growing imperative to explore how holistic digital platforms can be implemented effectively in oncology within resource-constrained settings. Objective: This study aimed to investigate the barriers and facilitators influencing the scalability and adoption of a comprehensive e-health solution in cancer care, drawing on a realist paradigm to determine what works, for whom, and under which circumstances, in the context of Jordan. Methods: A qualitative study, underpinned by a realist paradigm, was conducted using in-depth, semi-structured interviews with oncology healthcare professionals from diverse clinical settings in Jordan. Interviews were conducted in Arabic, translated into English, and analyzed using a hybrid inductive-deductive framework approach. The Implementation of Change Model guided interpretation of the findings, enabling the identification of multi-level contextual influences. Results: The analysis yielded a central theme- Conclusion: This study provides novel, contextually grounded insights into the implementation dynamics of digital transformation in oncology within MICs. It offers actionable guidance for policymakers and system designers aiming to foster sustainable, equitable digital-health ecosystems.

Indexed as

Holistic HealthNeoplasmsTelemedicineAdultDelivery of Health CareFemaleHealth PersonnelHumansInterviews as TopicJordanMaleMiddle AgedQualitative Researchcancer caredigital-health integratione-healthholistic digital platformsimplementation sciencemiddle-income countriesoncologyrealist evaluation

Identifiers

PMID41415251
PMCPMC12708916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.